Alan G. Shand

2.3k total citations
43 papers, 1.2k citations indexed

About

Alan G. Shand is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Alan G. Shand has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 22 papers in Genetics and 13 papers in Surgery. Recurrent topics in Alan G. Shand's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (18 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Alan G. Shand is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (18 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Alan G. Shand collaborates with scholars based in United Kingdom, United States and Türkiye. Alan G. Shand's co-authors include Ian Arnott, Jack Satsangi, Gwo‐Tzer Ho, Charlie W. Lees, Colin Noble, Nicola C. Hare, Michael A. Kamm, Anton Emmanuel, R. G. Wilson and Malcolm G. Dunlop and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Alan G. Shand

40 papers receiving 1.2k citations

Peers

Alan G. Shand

GENET

EPIDE

SURGE

IMMUN

Nobuyuki Hida Japan

Federica Nuti Italy

Klaudia Farkas Hungary

Roberta Pica Italy

Anna Zholudev United States

Gillian Watermeyer South Africa

Alicia C Marín Spain

Isolde Aerden Belgium

Lani Prideaux Australia

Jens Kelsen Denmark

Nobuyuki Hida Japan

Alan G. Shand

691 ×0.9

GENET

496 ×0.8

EPIDE

422 ×1.1

SURGE

337 ×1.5

IMMUN

165 ×1.4

Citations per year, relative to Alan G. Shand Alan G. Shand (= 1×) peers Nobuyuki Hida

Countries citing papers authored by Alan G. Shand

Since Specialization

Citations

This map shows the geographic impact of Alan G. Shand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Shand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Shand more than expected).

Fields of papers citing papers by Alan G. Shand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Shand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Shand. The network helps show where Alan G. Shand may publish in the future.

Co-authorship network of co-authors of Alan G. Shand

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Shand. A scholar is included among the top collaborators of Alan G. Shand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Shand. Alan G. Shand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Gareth‐Rhys, et al.. (2021). P109 Vedolizumab is an effective treatment for antibiotic refractory chronic pouchitis. A98.1–A98.

Jones, Gareth‐Rhys, Mathew Lyons, Nikolas Plevris, et al.. (2019). IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology. Gut. 68(11). 1953–1960. 137 indexed citations

Plevris, Nikolas, Gareth‐Rhys Jones, Philip Jenkinson, et al.. (2018). Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes. Digestive Diseases and Sciences. 64(6). 1660–1667. 28 indexed citations

Blackmur, James P., Fiona A. Chapman, Christopher Bellamy, et al.. (2013). Anti-TNF- therapy for renal amyloid as a complication of Crohn's disease. QJM. 107(1). 57–59. 7 indexed citations

Kennedy, Nicholas A., Nicola C. Hare, Gwo‐Tzer Ho, et al.. (2012). PTU-123 Acute severe ulcerative colitis: the last 12 years in Edinburgh: Abstract PTU-123 Figure 1. Gut. 61(Suppl 2). A235.2–A236. 2 indexed citations

Leighton, S. E. J., Caroline Gordon, & Alan G. Shand. (2011). Clopidogrel, Turkey and a red herring?. BMJ Case Reports. 2011. bcr0120113776–bcr0120113776. 2 indexed citations

Ho, Gwo‐Tzer, Gordon Brydon, Nicola C. Hare, et al.. (2009). Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis. The American Journal of Gastroenterology. 104(3). 673–678. 116 indexed citations

Lees, Charlie W., Julia Critchley, Thomas Beez, et al.. (2009). Lack of association between cervical dysplasia and IBD: A large case–control study. Inflammatory Bowel Diseases. 15(11). 1621–1629. 66 indexed citations

Din, Shahida, et al.. (2008). Use of methotrexate in refractory Crohnʼs disease: The Edinburgh experience. Inflammatory Bowel Diseases. 14(6). 756–762. 21 indexed citations

10.

Ho, Gwo‐Tzer, Lindsay Potts, A Cahill, et al.. (2008). Efficacy and complications of adalimumab treatment for medically‐refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004–2008). Alimentary Pharmacology & Therapeutics. 29(5). 527–534. 44 indexed citations

11.

Lees, Charlie W., et al.. (2008). 967 Cervical Dysplasia and Inflammatory Bowel Disease: No Effect of Disease Status or Immunosuppressants On Analysis of 2,199 Smear Records. Gastroenterology. 134(4). A–143. 4 indexed citations

12.

Lees, Charlie W., Gwo‐Tzer Ho, Colin Noble, et al.. (2007). A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics. 26(3). 411–419. 109 indexed citations

13.

Love, Seth, et al.. (2004). Dissemination of Brain Emboli following Captive Bolt Stunning of Sheep: Capacity for Entry into the Systemic Arterial Circulation. Journal of Food Protection. 67(5). 1050–1052. 7 indexed citations

14.

Shand, Alan G. & Alastair Forbes. (2003). Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab?. International Journal of Colorectal Disease. 18(1). 1–11. 15 indexed citations

15.

Shand, Alan G., et al.. (2002). Gastric fundic gland polyps in south‐east Scotland: Absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology. 17(11). 1161–1164. 21 indexed citations

16.

Shand, Alan G., et al.. (2002). Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro. Digestive and Liver Disease. 34(6). 430–438. 54 indexed citations

17.

Love, Seth, Chris R. Helps, Alan G. Shand, et al.. (2000). Methods for detection of haematogenous dissemination of brain tissue after stunning of cattle with captive bolt guns. Journal of Neuroscience Methods. 99(1-2). 53–58. 24 indexed citations

18.

Shand, Alan G., et al.. (1997). Palliation of a malignant gastrocolic fistula by endoscopic human fibrin sealant injection. European Journal of Gastroenterology & Hepatology. 9(10). 1009–1011. 7 indexed citations

19.

Shand, Alan G., et al.. (1997). Endoscopic fibrin sealant injection: a novel method of closing a refractory gastrocutaneous fistula. Gastrointestinal Endoscopy. 46(4). 357–358. 29 indexed citations

20.

Paterson, James, et al.. (1962). Groundnut toxicity as the cause of exudative hepatitis (oedema disease) of guinea-pigs.. Veterinary Record. 74. 639–640. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact